Veteran Cancer Talk

Dr. Elizabeth O’Donnell - Multicancer Early Detection: A Blood Test Revolution for Veterans?

Casey Kroner Season 1 Episode 9

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 19:34

Send us Fan Mail

In this episode of Veteran Cancer Talk, Ashton speaks with Dr. Elizabeth O’Donnell, Director of the Multicancer Early Detection Clinic at the Dana-Farber Cancer Institute, about one of the most promising developments in oncology: multicancer early detection (MSED) testing.

MSED tests use a single blood draw to analyze DNA methylation signatures that may indicate the presence of cancer. Some commercially available tests can screen for up to 50 different types of cancer — including many that currently have no recommended screening options.

Dr. O’Donnell explains:

 • How MSED testing works
 • Why these tests complement — not replace — traditional screenings
 • The Sentinel Study evaluating MSED in veterans
 • Eligibility requirements for participation
 • What happens after an abnormal result
 • Current limitations and false positive rates
 • The future of early cancer detection and Medicare reimbursement

This conversation explores how emerging blood-based screening tools could reshape cancer detection — particularly for veterans who may face elevated cancer risks due to service-related exposures.

To learn more about the Sentinel Study or Veteran Cancer Network, visit:
 www.veterancancernetwork.org  or  https://www.sentinelstudy.com/

Support the show

Veteran Cancer Network is building the resource we wish we had. Connecting veterans and caregivers navigating cancer.


Learn more at www.veterancancernetwork.org